This table presents recent patent oppositions filed by Betapharm Arzneimittel Gmbh against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3494972Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARE COMPANYSep 11, 2024
EP3626270New UseNOVARTIS AGJul 2, 2024
EP3294283Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS AGDec 7, 2023
EP2959894S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS AGJul 12, 2023
EP3461503Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICAL INC.Oct 28, 2022
EP2545939Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICAL INC.Sep 15, 2021
EP2340828Pharmaceutical Combinations Of An Angiotensin Receptor Antagonist And An Nep InhibitorNOVARTIS AGApr 15, 2021
EP2493466Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA S.A.Mar 31, 2021
EP3395338Rapid Dissolution Formulation Of Cinacalcet HclAMGENDec 9, 2020
EP3395339Rapid Dissolution Formulation Of A Cinacalcet HclAMGENDec 9, 2020